273 related articles for article (PubMed ID: 27592803)
1. Engineered Liver Platforms for Different Phases of Drug Development.
Ware BR; Khetani SR
Trends Biotechnol; 2017 Feb; 35(2):172-183. PubMed ID: 27592803
[TBL] [Abstract][Full Text] [Related]
2. The application of engineered liver tissues for novel drug discovery.
Lin C; Ballinger KR; Khetani SR
Expert Opin Drug Discov; 2015 May; 10(5):519-40. PubMed ID: 25840592
[TBL] [Abstract][Full Text] [Related]
3. Biofabrication of a three-dimensional liver micro-organ as an in vitro drug metabolism model.
Chang R; Emami K; Wu H; Sun W
Biofabrication; 2010 Dec; 2(4):045004. PubMed ID: 21079286
[TBL] [Abstract][Full Text] [Related]
4. Microengineered liver tissues for drug testing.
Khetani SR; Berger DR; Ballinger KR; Davidson MD; Lin C; Ware BR
J Lab Autom; 2015 Jun; 20(3):216-50. PubMed ID: 25617027
[TBL] [Abstract][Full Text] [Related]
5. Advances in Engineered Liver Models for Investigating Drug-Induced Liver Injury.
Lin C; Khetani SR
Biomed Res Int; 2016; 2016():1829148. PubMed ID: 27725933
[TBL] [Abstract][Full Text] [Related]
6. A Bioprinted Liver-on-a-Chip for Drug Screening Applications.
Knowlton S; Tasoglu S
Trends Biotechnol; 2016 Sep; 34(9):681-682. PubMed ID: 27291461
[TBL] [Abstract][Full Text] [Related]
7. Microfabrication of liver and heart tissues for drug development.
Brown GE; Khetani SR
Philos Trans R Soc Lond B Biol Sci; 2018 Jul; 373(1750):. PubMed ID: 29786560
[TBL] [Abstract][Full Text] [Related]
8. Engineered Microvessels for the Study of Human Disease.
Rayner SG; Zheng Y
J Biomech Eng; 2016 Nov; 138(11):1108011-11080111. PubMed ID: 27537085
[TBL] [Abstract][Full Text] [Related]
9. Application potential of mesenchymal stem cells derived from Wharton's jelly in liver tissue engineering.
Zhang L; Zhao YH; Guan Z; Ye JS; de Isla N; Stoltz JF
Biomed Mater Eng; 2015; 25(1 Suppl):137-43. PubMed ID: 25538064
[TBL] [Abstract][Full Text] [Related]
10. A pump-free microfluidic 3D perfusion platform for the efficient differentiation of human hepatocyte-like cells.
Ong LJY; Chong LH; Jin L; Singh PK; Lee PS; Yu H; Ananthanarayanan A; Leo HL; Toh YC
Biotechnol Bioeng; 2017 Oct; 114(10):2360-2370. PubMed ID: 28542705
[TBL] [Abstract][Full Text] [Related]
11. Open-Porous Hydroxyapatite Scaffolds for Three-Dimensional Culture of Human Adult Liver Cells.
Finoli A; Schmelzer E; Over P; Nettleship I; Gerlach JC
Biomed Res Int; 2016; 2016():6040146. PubMed ID: 27403430
[TBL] [Abstract][Full Text] [Related]
12. A human liver microphysiology platform for investigating physiology, drug safety, and disease models.
Vernetti LA; Senutovitch N; Boltz R; DeBiasio R; Shun TY; Gough A; Taylor DL
Exp Biol Med (Maywood); 2016 Jan; 241(1):101-14. PubMed ID: 26202373
[TBL] [Abstract][Full Text] [Related]
13. Intelligent freeform manufacturing of complex organs.
Wang X
Artif Organs; 2012 Nov; 36(11):951-61. PubMed ID: 22888830
[TBL] [Abstract][Full Text] [Related]
14. Selective control of liver and kidney cells migration during organotypic cocultures inside fibronectin-coated rectangular silicone microchannels.
Leclerc E; Baudoin R; Corlu A; Griscom L; Luc Duval J; Legallais C
Biomaterials; 2007 Apr; 28(10):1820-9. PubMed ID: 17178157
[TBL] [Abstract][Full Text] [Related]
15. Micro and nanotechnologies in heart valve tissue engineering.
Hasan A; Saliba J; Pezeshgi Modarres H; Bakhaty A; Nasajpour A; Mofrad MRK; Sanati-Nezhad A
Biomaterials; 2016 Oct; 103():278-292. PubMed ID: 27414719
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity evaluation using cryopreserved primary human hepatocytes in various culture formats.
Richert L; Baze A; Parmentier C; Gerets HHJ; Sison-Young R; Dorau M; Lovatt C; Czich A; Goldring C; Park BK; Juhila S; Foster AJ; Williams DP
Toxicol Lett; 2016 Sep; 258():207-215. PubMed ID: 27363785
[TBL] [Abstract][Full Text] [Related]
17. Biomimetic cardiac microsystems for pathophysiological studies and drug screens.
Lee J; Razu ME; Wang X; Lacerda C; Kim JJ
J Lab Autom; 2015 Apr; 20(2):96-106. PubMed ID: 25524490
[TBL] [Abstract][Full Text] [Related]
18. Current limitations and future opportunities for prediction of DILI from in vitro.
Funk C; Roth A
Arch Toxicol; 2017 Jan; 91(1):131-142. PubMed ID: 27766365
[TBL] [Abstract][Full Text] [Related]
19. Micropatterned organoid culture of rat hepatocytes and HepG2 cells.
Mori R; Sakai Y; Nakazawa K
J Biosci Bioeng; 2008 Sep; 106(3):237-42. PubMed ID: 18929998
[TBL] [Abstract][Full Text] [Related]
20. Assessment of metabolism-dependent drug efficacy and toxicity on a multilayer organs-on-a-chip.
Li Z; Guo Y; Yu Y; Xu C; Xu H; Qin J
Integr Biol (Camb); 2016 Oct; 8(10):1022-1029. PubMed ID: 27605158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
